Integer Holdings (ITGR) Total Current Liabilities (2010 - 2026)
Integer Holdings (ITGR) reported Total Current Liabilities of $206.3 million for Q2 2026, little changed on a YoY basis from $206.4 million in Q2 2025, and down 11.07% sequentially from $232.0 million in Q4 2025.
Integer Holdings (ITGR) Total Current Liabilities (2010 - 2026) Analysis & Trends
Integer Holdings (ITGR) has 17 years of Total Current Liabilities data on file, last reported at $206.3 million in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities changed 0.03% year-over-year to $206.3 million; the trailing twelve-month figure through Apr 2026 stood at $206.3 million (changed 0.03% YoY), and the FY2025 full-year result was $232.0 million, up 2.14% from the prior year.
- Total Current Liabilities retreated to $206.3 million in Q2 2026, from $232.0 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $232.0 million in Q4 2025 to a low of $173.1 million in Q2 2022.
- A 5-year average of $210.0 million and a median of $206.4 million in 2025 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities jumped 40.17% in 2022 and dropped 10.66% in 2024, its largest moves.
- Tracing ITGR's Total Current Liabilities over 5 years: stood at $223.8 million in 2022, then slipped by 1.24% to $221.0 million in 2023, then advanced by 2.81% to $227.2 million in 2024, then increased by 2.14% to $232.0 million in 2025, then retreated by 11.07% to $206.3 million in 2026.
- Business Quant data shows ITGR's Total Current Liabilities at $206.3 million in Q2 2026, $232.0 million in Q4 2025, and $209.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Integer Holdings | 3.34 Bn | 3.33 Bn | 109.60 Mn | 206.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 206.34 Mn |
| Dec 31, 2025 | 232.04 Mn |
| Sep 26, 2025 | 209.82 Mn |
| Jun 27, 2025 | 216.03 Mn |
| Mar 28, 2025 | 206.40 Mn |
| Dec 31, 2024 | 227.17 Mn |
| Sep 27, 2024 | 222.40 Mn |
| Jun 28, 2024 | 205.99 Mn |
| Mar 29, 2024 | 201.43 Mn |
| Dec 31, 2023 | 220.97 Mn |
| Sep 29, 2023 | 203.10 Mn |
| Jun 30, 2023 | 199.83 Mn |
| Mar 31, 2023 | 225.48 Mn |
| Dec 31, 2022 | 223.75 Mn |
| Sep 30, 2022 | 198.76 Mn |
| Jul 1, 2022 | 197.73 Mn |
| Apr 1, 2022 | 173.08 Mn |
| Dec 31, 2021 | 159.63 Mn |
| Oct 1, 2021 | 156.41 Mn |
| Jul 2, 2021 | 164.13 Mn |